PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 39: Articles 19001-19500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraception and the under-16s.
  2. Contraception and the use of health care systems. [Contraception et recours au systeme de soins.]
  3. Contraception by IUDs: results of a ten year study. [La contraception par dispositifs intrau-uterins: resultats de dix ans de surveillance.]
  4. Contraception by periodic abstinence or lactational anovulation.
  5. Contraception during lactation: considerations in advising the individual and in formulating programme guidelines.
  6. Contraception for men: where do general practitioners stand?
  7. Contraception for the adolescent.
  8. Contraception for the older woman--a review.
  9. Contraception for the older woman.
  10. Contraception in adolescence. [Anticoncepcion en la adolescencia.]
  11. Contraception in adolescence: knowing is not enough. [La contraception a l'adolescence: savoir ne suffit pas.]
  12. Contraception in adolescents. [Empfangnisverhutung bei Jugendlichen.]
  13. Contraception in Flanders (excerpts) [Anticonceptie in Vlaanderen.]
  14. Contraception in France, a study of current use, knowledge and perceptions of contraceptive methods.
  15. Contraception in France: a study of current use, knowledge and perceptions of contraceptive methods.
  16. Contraception in Great Britain.
  17. Contraception in Great Britain: a 1985 IHF survey.
  18. Contraception in Spain, a study of current use, knowledge and perceptions of contraceptive methods.
  19. Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel. [Contraception chez la femme hypertendue par un anneau vaginal delivrant l'estradiol et le norgestrel.]
  20. Contraception in the mentally handicapped. [Kontrazeption bei geistig Behinderten.]
  21. Contraception in the Soviet Union.
  22. Contraception in women over forty. [La contraception feminine apres 40 ans.]
  23. Contraception in women suffering from systemic lupus ethymatosus. [La contraception chez les femmes atteintes de lupus erythemateux dissemine.]
  24. Contraception prevalence: the influence of organized family planning programs.
  25. Contraception research lagging.
  26. Contraception without risk of breast disease: epidemiologic and physiopathologic arguments. [Elements pour une contraception sans risque mammaire: arguments epidemiologiques et physio-pathologiques.]
  27. Contraception, copulation domination, and the theoretical barrenness of sex education literature.
  28. Contraception, sterilisation and infertility.
  29. Contraception: liberation or threat? [Anticonceptie: bevrijding of bedreiging?]
  30. Contraception: dilemmas for the relatively infertile.
  31. Contraception: Gallup poll.
  32. Contraception: where are we in 1985?
  33. Contraception: your questions answered.
  34. Contraceptions among young unwed women: problems of today. [Le contraceptions chez les jeuenes filles celibataires: problemes d'actualite.]
  35. Contraceptive (drugs) Prevalence Survey. [Encuesta de Prevalencia de Medicamentos.]
  36. Contraceptive advertising on tv--still a "no-no"]
  37. Contraceptive behavior in college-age males related to Fishbein model.
  38. Contraceptive choice.
  39. Contraceptive decision-making in urban, black female adolescents: its relationship to cognitive development.
  40. Contraceptive distribution in factories in St. Lucia, conducted by Tulane University under Contract AID/DPE-0632-C-00-2007-00, November 1982 to February 1985.
  41. Contraceptive efficacy of bioabsorbable pellets of norethindrone (NET) as subcutaneous implants: Phase II clinical study.
  42. Contraceptive futurology or 1984 in 1984 [editorial]
  43. Contraceptive futurology: or 1984 in 1984.
  44. Contraceptive habits in women born in 1936. Results of a health survey at ages 40 and 45. [Kontraceptionsvaner hos kvinder af argang 1936. Resultater fra helbredsundersogelse i 40- og 45-ars alderen.]
  45. Contraceptive implants.
  46. Contraceptive knowledge among those getting married. [Osvedomlennost' vstupayushchikh v brak o metodakh i sredstvakh kontratseptsii.]
  47. Contraceptive knowledge and use of birth control as a function of sex guilt.
  48. Contraceptive knowledge, use, and attitudes among Dominican men: results from the 1984 Male Contraceptive Prevalence Survey.
  49. Contraceptive method switching among American female adolescents, 1979.
  50. Contraceptive methods for adolescents. [Les methodes contraceptives chez l'adolescente.]
  51. The contraceptive pill and cancer risks: what is the evidence after 20 years experience?
  52. Contraceptive practice in the Philippines: a synthesis.
  53. Contraceptive practices of women attending the Sexually Transmitted Disease Clinic in Nashville, Tennessee.
  54. Contraceptive prevalence in Montserrat.
  55. Contraceptive prevalence in St. Kitts-Nevis.
  56. Contraceptive prevalence rates in Bangladesh--some preliminary results based on a new service statistics system.
  57. Contraceptive product advertising.
  58. Contraceptive product advertising: the facts.
  59. Contraceptive retail surveys locate problems of acceptance.
  60. The contraceptive role of breastfeeding by educational attainment: an assessment based on Malaysian fertility and family survey.
  61. The contraceptive role of breastfeeding.
  62. Contraceptive rumor, misinformation and oral pill use in Egypt.
  63. Contraceptive social marketing in three Eastern Caribbean countries: report of the Second Monitoring Survey.
  64. Contraceptive social marketing.
  65. Contraceptive social marketing: a continuous cycle of planning, testing and evaluating.
  66. The contraceptive sponge.
  67. Contraceptive terminology: a glossary for the fields of contraception, reproductive health, and demography. Draft.
  68. Contraceptive trends in patients opting for medical termination of pregnancy.
  69. Contraceptive usage during lactation in the United States: an update.
  70. Contraceptive use among married women of childbearing age. [Wallchart]
  71. Contraceptive use and fertility in Guatemala.
  72. Contraceptive use and fertility in Thailand: results from the 1984 contraceptive prevalence survey.
  73. Contraceptive use before and after induced abortion. [Prevensjon for og etter legal abort.]
  74. Contraceptive use before tubal sterilization.
  75. Contraceptive use during lactation in developing countries.
  76. Contraceptive use in adolescent females and its relation to cognitive developmental status and identity formation.
  77. Contraceptive use, amenorrhea, and breastfeeding in postpartum women.
  78. Contraceptive use.
  79. Contraceptives and the under 16s [letter]
  80. Contraceptives and the under 16s [letter]
  81. Contraceptives and the under 16s [letter]
  82. Contraceptives and the under 16s [letter]
  83. Contraceptives distributed to postpartum clients: quarterly reporting forms.
  84. Contraceptives for the relatively infertile.
  85. A contribution to the study of maternal and child health and family planning in the city of Bangui and in the rural regions of Bambari: (behavioral study). Central African Republic. [Contribution a l'etude des activites de sante maternelle et infantile et de planning familial dans la ville de Bangui et dans les regions rurales de Bambari (etude du comportement), (Republique Centrafricaine)]
  86. Contribution to the study of the mode of contraceptive action of intrauterine devices. Does the IUD act before or after fertilization? [Contribution a l'etude du mode d'action des dispositifs intra-uterins. Le "sterilet" agit-il avant ou apres la fecondation?]
  87. Contributions of sex guilt and masturbation guilt to women's contraceptive attitudes and use.
  88. Counseling on contraceptives: an unfilled need.
  89. Counselling in family planning [letter]
  90. Court of appeal rules DHSS notice on family planning contrary to law.
  91. Coverage of family planning services in five health regions. [Cobertura de los servicios de planificacion familiar en cinco regiones de salud.]
  92. A critique of the methodologies to measure the demographic impact of family planning programmes.
  93. A cross-country study of commercial contraceptive sales programs: factors that head to success.
  94. Current family planning work viewed from results of the National Fertility Sample Survey.
  95. Current issues in contraception. [Actualites en contraception.]
  96. The current state of family planning program evaluation.
  97. Current status of family planning in Nigeria.
  98. Current status of NORPLANT subdermal implants for contraception.
  99. Current trends in the development of oral contraception.
  100. Current use of contraception.
  101. The current use of microcomputers in demography and family planning in developing countries.
  102. Cutaneous effects in hormonal contraception. [Bilan cutane de la contraception hormonale.]
  103. The Dalkon Shield: a troubled legacy. Questions arose early on contraceptive's safety.
  104. De-mystifying research for the development of contraceptive social marketing projects.
  105. The demographic, health, economic and social impact of family planning in selected African countries.
  106. Denmark. Law No. 236 of 23 May 1984 amending the law on health measures during pregnancy and obstetric assistance (duties of county authorities to provide guidance on contraceptive methods, etc.)
  107. Depo-Provera highly effective as injectable contraceptive.
  108. Description for the selection of services for the family planning and health home distribution project, PRODEF, Bas Zaire.
  109. Design and assessment processes in short term training programs for family planning, primary health care and nutrition program management.
  110. Designating types of OCs in family planning agency can save money.
  111. The determinants of contraceptive use and fertility in Mexico.
  112. Determinants of contraceptive use in Bangladesh.
  113. Determinants of contraceptive use in Nepal.
  114. Determinants of high family planning practices: a case study of Nilgiris.
  115. Determination of caffeine and metamizole elimination in men and women with and without hormonal contraceptives as an in vivo method characterizing various cytochrome P-450 subspecies. [Die Bestimmung der coffein-und Metamizolelimination bei Mannern und Frauen ohne sowie unter hormonalen Kontrazeptiva als in-vivo-Methode zur Charakterisierung verschiedener cytochrom P-450 subspezies.]
  116. Determination of ovulation by assay of the luteinising hormone in the urine of adolescent girls prior to the prescription of oral contraceptives. [La determination de l'ovulation par l'examen de l'hormone luteinisante dans l'urine des adolescentes, avant la prescription des contraceptifs oraux.]
  117. Development of a decision aid for women choosing a method of birth control.
  118. Diagnostic study of population growth, family planning and development in Uttar Pradesh, 1971-81.
  119. Differential factors affecting in acceptance of family planning among the working and non-working women in Bangladesh.
  120. Differentiation of current users and of non-users of family planning, Philippines, 1983.
  121. Discriminant analysis as a method for differentiating potential acceptors of family planning: western Samoa.
  122. Discussion: clinical concerns with intrauterine contraception.
  123. Discussion: technical advances in intrauterine contraception.
  124. Discussion: worldwide experience with intrauterine contraception.
  125. Disease and contraception. Recent aspects. [Pathologie et contraception. Quelques aspects recents.]
  126. Disorders of the internal ear through oral contraceptives? [Innenohrstorungen durch orale hormonale Kontrazeptiva?]
  127. The distribution channels of contraceptives in Japan.
  128. Do contraceptive methods pose fetal risks?
  129. Do family planning work in a Chinese way.
  130. Do oral contraceptives prevent rheumatoid arthritis?
  131. Do's and don'ts in post-partum contraception. [Faites...ne faites pas... dans la contraception du post-partum.]
  132. Doctors' meet on hormonal contraception -- practical aspects.
  133. Does family planning work in a Chinese way.
  134. Does practice make perfect: the effect of early contraceptive use on unwanted fertility.
  135. The Dominica male family planning survey country report 1982.
  136. Dominican Republic: National Contraceptive Prevalence Survey -- Men. Report of findings, 1984-1985. [Republica Dominicana: Encuesta Nacional de Prevalencia de Anticonceptivos: -- Hombres. Informe de Resultados, 1984-1985.]
  137. Drug interactions in the use of steroid hormones, especially oral contraceptives. [Arzneimittelinteraktionen bei der Anwendung von Steroidhormonen, insbesondere von oralen Kontrazeptiva.]
  138. Early diagnosis and management of abnormalities and contraception during the puerperal period.
  139. The economics of family planning.
  140. Effect of a once-a-month oral contraceptive on serum prolactin levels.
  141. The effect of child mortality on contraceptive use and fertility in Colombia, Costa Rica and Korea.
  142. The effect of contraceptive knowledge source upon knowledge accuracy and contraceptive behavior.
  143. Effect of early postpartum use of the contraceptive implants, Norplant, on the serum levels of immunoglobulins of the mothers and their breastfed infants.
  144. Effect of family planning on the health of the mother and child. [Effet du planning familial sur la sante de la mere et de l'enfant.]
  145. Effect of hormonal contraceptives on the activity of various enzymes in blood serum. [Der Einfluss hormonaler Kontrazeptiva auf die Aktivitat verschiedener Enzyme im Blutserumm.]
  146. Effect of hormonal contraceptives on the coagulation system with special reference to its inhibitors. [A hormonalis fogamzasgatlok hatasa az alvadas-rendszerre, kulonos tekintettel annak nehany inhibitorara.]
  147. Effect of microwave contraception on human serum testosterone and luteinizing hormone.
  148. Effect of oral contraceptive agents on thiamine status.
  149. The effect of oral contraceptive drug on cardiovascular system, liver and kidneys.
  150. The effect of oral contraceptive formulation and field-workers: a cautionary tale.
  151. Effect of oral contraceptive use on the erythrocytic glutathione reductase and aspartate aminotransferase activities in women with or without clinical signs of vitamin deficiency.
  152. Effect of oral contraceptives and some psychological factors on the menstrual experience.
  153. Effect of oral contraceptives on serum lipids and cardiovascular disease.
  154. Effect of postcoital contraceptive levonorgestrel (Postinor) on endometrial oestradiol binding.
  155. Effectiveness of injectable contraceptives in Mexican women. [Eficacia de anticonceptivos inyectables en mujeres Mexicanas.]
  156. The effects of a combination of cigarette smoking and oral contraception on coagulation and fibrinolysis in human females.
  157. The effects of contraceptive intent, social support, conjugal communication and power, and desire for more children on contraceptive behavior in the Philippines.
  158. Effects of family planning on infant health. [Effets du planning familial sur la sante de l'enfant.]
  159. The effects of family planning programs on fertility in the developing world.
  160. The effects of government policies on family planning programs.
  161. The effects of long-acting injectable contraceptives on carbohydrate metabolism.
  162. Effects of oral contraceptive usage on B12 and folate levels.
  163. Effects of oral contraceptives and obesity on Protein-C antigen.
  164. Effects of oral contraceptives on blood coagulation. A review.
  165. Effects of pregnancy, postpartum lactation, and oral contraceptive use on the lipoprotein cholesterol/ triglyceride ratio.
  166. Effects of short-term treatment with a combined oestrogen-progestin oral contraceptive on biliary lipids and cholesterol saturation index in young women.
  167. Effects of the contraceptive pill on sedative responses to clonidine and apomorphine in normal women.
  168. Effects of U.S. decision to withdraw aid for international family planning programs.
  169. Effects of US decision to withdraw aid for worldwide family planning programmes.
  170. Efficacy and physiology of a triphasic oral contraceptive.
  171. Endometrial estrogen and progesterone receptors in women wearing intrauterine contraceptive devices.
  172. Epidemiologic trends of PID in contraceptive use.
  173. The epididymis as a target for contraception: role of testosterone metabolism.
  174. Erythrocyte cation transport is sex-related and is modified by oral contraceptives.
  175. Estimating required contraceptive prevalence.
  176. Ethical issues in family planning.

     

  177. Ethnicity, locus of control for family planning, and pregnancy counselor credibility.
  178. Evaluating the effectiveness of utilizing traditional birth attendants for maternal and child health/family planning programs in the rural Philippines.
  179. Evaluating unmet need for contraception: estimates for thirty-six developing countries.
  180. Evaluation of Family Planning Films Project: the pretest report.
  181. Evaluation of family planning in Ogun State: importance and process in Abeokuta, Ogun State.
  182. Evaluation of family planning programmes. Report on three country-level studies. Multinational Pilot Study on the Evaluation of Family Planning Programmes.
  183. Evaluation of Kenya's National Family Welfare Center program of in-service family planning training for enrolled community nurses and clinical officers.
  184. Evaluation of print materials for nonliterates in family planning programs.
  185. Evaluation of the cancer risk of intrauterine contraception based on cytological studies of the endometrium. [Otsenka onkologicheskogo riska vnutrimatochnoi kontratseptsii na osnove tsitologicheskikh issledovanii endometriia.]
  186. Evaluation of the Caribbean Contraceptive Social Marketing Project in three countries. Conducted by Tulane University under Contract AID/DPE-0632-C-00-2007-00.
  187. Evaluation of the contraceptive implant method: statistical considerations and medical and psychosocial aspects. [La valutazione del metodo dell'impianto nella contraccezione: considerazioni statistiche, aspetti medici e psico-sociali.]
  188. Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception. [Appreciation de l'efficacite d'une association veinotonique protecteur capillaire comme traitement des metrorragies de la contraception par D.I.U. ou par micropilule.]
  189. Evaluation of the impact of family planning programmes on fertility: the case of Colombia.
  190. Evaluation of the impact of family planning programmes on fertility: the case of Costa Rica.
  191. Evaluation of the impact of family planning programmes on fertility: the case of Pakistan.
  192. Evaluation of the impact of family planning programmes on fertility: the case of Sri Lanka.
  193. Evaluation of the impact of family planning programs on fertility: the case of Pakistan.
  194. Evaluation of the impact of family planning programs on fertility: the case of Sri Lanka.
  195. Evidence for an increased risk of Crohns' disease in oral contraceptive users.
  196. Experience in using intrauterine contraceptive devices by women with chronic pyelonephritis. [Opyt primeneniia vnutrimatochnykh protivozachatochnykh sredstv u zhenshchin, stradaiushchikh khronicheskim pielonefritom.]
  197. Experience with a combined multiload contraceptive device.
  198. Experience with GYNE-T Cu-380-A intrauterine contraceptive device (1981-1984)
  199. The eye and hormones: vascular disorders associated with combined oral contraceptives and pregnancy. [Oeil et hormones: pathologie vasculaire au cours de la prise d'oestroprogestatifs et au cours de la grossesse.]
  200. Factors affecting contraceptive use in Pakistan: a multivariate analysis.
  201. Factors against contraception. [Les factuers de resistance a la contraception.]
  202. Factors associated with contraceptive use.
  203. Factors associated with the perception of side-effects relating to the use of contraceptive methods.
  204. Factors causing differentials between contraceptive knowledge and practice in rural Bangladesh.
  205. Factors in adolescent contraceptive use.
  206. Factors influencing the use of traditional versus modern family planning methods in Bas Zaire.
  207. Factors other than nuptiality and contraception affecting fertility.
  208. Facts about an implantable contraceptive: memorandum from a WHO meeting.
  209. Facts about injectable contraceptives.
  210. Failure of post-coital contraception after insertion of an intrauterine device. Authors' reply [letter]
  211. Failure of post-coital contraception after insertion of an intrauterine device. Case report [letter]
  212. Family life education program ideas: adolescent sexuality, family planning, talking to children about sex, domestic violence and sexual abuse, contemporary family programs, intergenerational and family relationships.
  213. Family of the Future: a contraceptive social marketing program in Egypt 1979-1985.
  214. Family planning and contraceptive needs in developing countries: a report of a symposium held on October 23, 1985 at Organon International B.V., Oss, The Netherlands.
  215. Family planning and contraceptives in China. [Planification familiale et pratiques contraceptives en Chine.]
  216. Family planning and culture.
  217. Family planning and family health. [Planification familiale et sante familiale.]
  218. Family planning and health interventions in the Sudan: an updated report.
  219. Family planning and maternal and child health programs in Japan.
  220. Family planning and medical demography. A multidisciplinary approach. [Planificacion familiar y demografia medica. Un enfoque multidisciplinario.]
  221. Family planning and religion: the case of Islam and Christianity. [Planification familiale et religion: cas de l'Islam et du Christianisme.]
  222. Family planning and sexual counselling.
  223. Family planning and the Emergency: an unanticipated consequence.
  224. Family planning and the global challenge [letter]
  225. Family planning and the law: other people's rights.
  226. Family planning and the well-being of women and children. An analysis of World Fertility Survey and other data.
  227. Family planning and women's health.
  228. Family planning and work. [Planification des naissances et travail.]
  229. Family planning as an essential part of primary health care and of development strategy. [Planificacion familiar como parte esencial de la atencion primaria de salud y de la estrategia para el desarrollo.]
  230. Family planning as public policy. Ten years of family planning work in Portugal. [Familienplanung als offentliche Aufgabe. Zehn Jahre Familienplanungsarbeit in Portugal.]
  231. Family planning grantees, delegates, and clinics: 1985 directory.
  232. Family planning in a pro-natalist environment: the case of the Bolivian Industrial Project.
  233. Family planning in adolescents. [La pianificazione familiare nell'adolescente.]
  234. Family planning in Bangladesh.
  235. Family planning in general practice.
  236. Family planning in government plans. [Planejamento familiar nos planos governamentais.]
  237. Family planning in Japan -- an historical overview.
  238. Family planning in Poland between church and state. [Familienplanung in Polen zwischen Kirche und Staat.]
  239. Family planning in rural Lebanon 1983-1984. A report on the results of the Lebanon Contraceptive Prevalence Survey.
  240. Family planning in Scotland in 1982: a survey carried out on behalf of the Scottish Home and Health Department.
  241. Family planning in Shanghai.
  242. Family planning in SubSaharan Africa: a review of the findings from contraceptive prevalence surveys.
  243. Family planning in the South Pacific.
  244. Family planning in the United Kingdom: services and training.
  245. Family planning in Tunisia. [Le planning familial en Tunisie.]
  246. Family planning is beneficial to prosperity.
  247. Family planning management training: identification and assessment of U.S. training resources.
  248. Family planning must be part of the package. Interview: Shridath Ramphal.
  249. Family planning operations research project: St. Vincent and the Grenadines, Ministry of Health/Tulane University. Strategies for improving continuation rates among contraceptive acceptors. Final report.
  250. Family planning operations research: the PRODEF/Tulane project in Bas Zaire, final report.
  251. Family planning performance in India--a methodological approach.
  252. Family planning policies and programs in Africa.
  253. Family planning policy and its implementation in China.
  254. Family planning program effectiveness in developing countries: lessons learned.
  255. Family planning program funds: sources, levels, and trends.
  256. Fertility awareness/natural family planning for adolescents and their families: effect of parental involvement.
  257. Fertility effect of policy measures and programmes other than the family planning programme: methods of evaluation.
  258. Fertility effect of policy measures and programs other than the family planning programme: methods of evaluation.
  259. Fertility of couples following cessation of contraception.
  260. Fertility preference and family planning practices in rural Bangladesh--a case study.
  261. Fertility preferences and contraceptive use in Pakistan.
  262. Fertility preferences and utilization of family planning services.
  263. Fertility, contraceptive use, and socioeconomic context in Bangladesh [tables]
  264. Fertility, contraceptive use, and socioeconomic context in Bangladesh.
  265. Fertility, family planning and the status of women.
  266. Fibrinolytic activity and intrauterine contraceptive devices.
  267. A field study of worker performance in a community-based health/family planning project, Oyo State, Nigeria.
  268. Final report: accessibility and the adoption of family planning, the Korean Population Policy and Program Evaluation Study.
  269. Findings of a qualitative survey on attitudes towards, and knowledge of family planning, Jakarta 1985.
  270. A follow-up study of the efficacy and safety of injectable microencapsulated megestrol acetate and a discussion on its contraceptive mechanism.
  271. Future aspects in contraception. Proceedings of an International Symposium held in Heidelberg, 5-8 September 1984: Part 2, Female Contraception.
  272. Future directions in the analysis of contraceptive availability.
  273. The future growth of contraceptive practice in developing countries.
  274. The future of family planning in Sub-Saharan Africa.
  275. The future of plant-derived chemicals as contraceptive agents.
  276. Futures aspects in contraception: an overview.
  277. Gallbladder disease related to use of oral contraceptives and nausea in pregnancy.
  278. Gender differences in attitudes toward contraceptive use.
  279. Gestational diabetes in the past: a relative contraindication for intrauterine contraception.
  280. Ghana: contraceptives are familiar but little used; lactation plays primary role in limiting fertility.
  281. Girls under 16 do not need parental ok to obtain contraceptive services, says Britain's highest court.
  282. GMC defers decision on contraceptive advice to under 16s.
  283. Gonadal steroids in athletic women: contraception, complications and performance.
  284. Gonadotrophin-releasing hormone agonists for new approaches to contraception in man.
  285. Gonadotropin releasing hormone analogs for female contraception by inhibition of ovulation.
  286. Gonadotropin-releasing hormone (GnRH) analogues as contraceptive agents.
  287. Gonococcal pelvic inflammatory disease, oral contraceptives, and cervical mucus [letter]
  288. Gonorrhea in women using intrauterine contraceptive devices. [K problematike kvapavky u zien s vnutromaternicovou antikoncepciou.]
  289. Gossypol contraception and mechanism of action.
  290. Gossypol: a potential contraceptive for men.
  291. Grasping economic reform and family planning simultaneously.
  292. Great contribution of medical workers and good effect of birth control operation.
  293. Griseofulvin-oral contraceptive interaction [letter]
  294. A guide to modern contraceptive methods.
  295. A guide to modern contraceptive methods. [Wallchart]
  296. Guidelines for overcoming design problems in family planning operations research.
  297. Hair loss during treatment with oral contraceptives. [Chute des cheveux sous pilule.]
  298. A handbook for family planning fieldworkers.
  299. Health and family planning in community-based distribution programs.
  300. The health belief model and the contraceptive behavior of college women: implications for health education.
  301. Health education in family planning and maternal and child health in Indonesia.
  302. Health posts: providers of basic health care and family planning in the rural areas.
  303. Health systems research in maternal and child health including family planning: issues and priorities. Report of the meeting of the Steering Committee of the Task Force on Health Systems Research in Maternal and Child Health including Family Planning, New Delhi, 12-15 March 1984.
  304. Hemichorea and oral contraceptives. [Hemichoree et contraceptifs oraux.]
  305. Hemorrhage into a liver adenoma associated with long-term use of oral contraceptives. [Spontane Blutung in ein Leberadenom nach mehrjahriger Einnahme von Antikonzeptiva.]
  306. Hepatic adenoma and oral contraception: a hemorrhagic complication. [Adenome hepatique et contraception orale: a propos d'une complication hemorragique.]
  307. Hepatic adenoma and oral contraceptives: personal case. [Adenoma epatico e contraccettivi orali: osservazione personale.]
  308. Hepatic tumors and oral contraceptives: surgical management.
  309. Hereditary uroporphyrinogen-decarboxylase deficiency predisposing porphyria cutanea tarda (chronic hepatic porphyria) in females after oral contraceptive medication.
  310. High risk pregnancy and contraception.
  311. High tech natural family planning: the future of fertility control?
  312. Histochemical study of glycogen in the endometrium of women using intrauterine contraceptive devices. [Gistokhimiceskoe issledovanie glikogena v endometrii zhenshchin, primeniaiushchikh vnutrimatochnye protivozachatochnye sredstva.]
  313. Honduran physicians play key role in establishing voluntary surgical contraception.
  314. Honduras contraceptive social marketing program, audio-visual media messages.
  315. Hormonal contraception and cancer risk. [Hormonale Kontrazeption und Krebsrisiko.]
  316. Hormonal contraception: development and mode of action.
  317. Hormonal contraceptive methods.
  318. Hormonal contraceptives and singers' voices. [Gormonalnye kontratseptivy i pevcheskii golos.]
  319. Hormonal effects of GnRH agonist in the human male: an approach to male contraception using combined androgen and GnRH agonist treatment.
  320. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study.
  321. House of Lords rules DHSS guidance on contraception lawful.
  322. The how and why of natural family planning.
  323. How promiscuous are our teenagers? A study of teenage girls attending a family planning clinic.
  324. How the number of living sons influences contraceptive use in Menoufia Governorate, Egypt.
  325. How to design an integrated health and family planning project.
  326. The Hukka Group: a group dynamics approach to family planning communication in rural India.
  327. Husbands' sex-role preferences and contraceptive intentions: the case of the male pill.
  328. Hydrolysis of phospholipid monolayers by human spermatozoa. Inhibition by male contraceptive gossypol.
  329. Hypermasculinity and male contraceptive attitudes and behavior.
  330. Hypertension, heart disease and combined oral contraceptives. [Hypertension arterielle, pathologie cardiaque et oestroprogestatifs contraceptifs.]
  331. Ibadan market women project: an innovative approach to family planning services in urban Nigeria.
  332. The identification of candidate antigens for the development of birth control vaccines; an international multi-centre study on antibodies to reproductive tract antigens, using clinically defined sera.
  333. An illustrated history of contraception from antiquity to the present. [Histoire illustree de la contraception de l'Antiquite a nos jours.]
  334. Immunogenicity and the vascular risk of oral contraceptives.
  335. Impact of counseling on repeated unplanned pregnancy and contraceptive behavior in low SES abortion population.
  336. The impact of Indian government family planning instructional films on non-literate rural audiences: a case study, 1983-1984.
  337. Implementation and expansion of family planning services: questions and controversies. [A implantacao e expansao dos servicos de planejamento familiar: questoes e controversias.]
  338. Implementing community health worker/family planning CBD through church health missions in Kenya: analysis of baseline family planning data.
  339. The implications of family planning on the health and welfare of mother and children in the developing world with special reference to Singapore.
  340. The importance of comprehensive family planning as suggested by Gangshang village.
  341. Importance of family planning prevalence surveys and their use in obtaining data for evaluation.
  342. Incidence of actinomycetes infection in women using intrauterine contraceptive devices.
  343. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
  344. Increased UDP-glucuronyltransferase in putative preneoplastic foci of human liver after long-term use of oral contraceptives.
  345. Indian Study Mission to China and Hong Kong, Ministry of Health and Family Welfare, Government of India. Study of family planning programmes and population incentives of the Chinese government, 14th December to 24th December 1985.
  346. Indicators of arterial blood pressure during hormonal contraception. [Pokazeteli arterialnogo davleniia pri gormonalnoi kontratseptsii]]
  347. Individual vs. group education in family planning clinics.
  348. Indonesia: East Java family planning, nutrition, and income generation project.
  349. The Indonesian experience in family planning.
  350. The Indonesian family planning program through charts and pictures. [Program keluarga berencana nasional dalam grafik dan gambar.]
  351. The Indonesian National Family Planning Program: implementation results in three five year development periods.
  352. Industrial settings for family planning promotion and services in La Paz, Bolivia: an operations research project.
  353. Infant feeding practices, postpartum amenorrhea, and contraceptive use in Thailand.
  354. Inflammatory changes in intrauterine contraceptive devices.
  355. The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
  356. The influence of contraceptive steroid delivery systems on clinical performance.
  357. The influence of family planning programmes on infant mortality levels.
  358. Influence of Norplant contraceptive implants on lactation and infant growth. [Influencia de los implantes anticonceptivos Norplant en la lactancia y el crecimiento de los ninos.]
  359. Influence of nurse-client contracting on family planning knowledge and behaviors in a university student population.
  360. The influence of oral contraceptive no. II on platelet function and blood coagulability.
  361. Influence of oral contraceptives and pregnancy on constituents of the kallikrein-kininogen system in plasma.
  362. Influence of progestins on adverse effects of oral contraceptives. [Influence des progestatifs sur les effets metaboliques indesirables de contraceptifs oraux.]
  363. Information and education program in family planning for men: the experience of CONAPOFA. [Programa de informacion y educacion en planificacion familiar para hombres: la experiencia de CONAPOFA.]
  364. Information, education and communication (IEC) -strategy on national family planning program with special reference to TV/video system.
  365. The information, education and communication program in family planning for men: the experience of PROFAMILIA. [Programa de comunicacion, educacion e informacion en planificacion familiar para hombres: la experiencia de PROFAMILIA.]
  366. Inhibin and male contraception.
  367. Inhibition of oral contraceptive effectiveness by concurrent antibiotic administration. A review.
  368. Inhibition of oral contraceptive efficacy.
  369. Injectable contraception.

     

  370. Injectable contraceptives.
  371. Injectable contraceptives.
  372. Injectable contraceptives: the role of long-acting progestagens in contraception in developing countries.
  373. Institutional report on the qualitative aspects of natural family planning practice among couples of Luzon.
  374. Integrated family planning for small farmers: a handbook. [Planeamento familiar integrado para pequenos agricultores: um manual.]
  375. Integrating individual and community data in the study of contraceptive behaviour.
  376. The integration of community-based family planning and development in Thailand: the role of the Population and Community Development Association.
  377. Intensifying demand generation for family planning methods in the industry sector: a preliminary proposal.
  378. Interactions between ethanol and oral contraceptive steroids.
  379. International family planning.
  380. International family planning: the reasons for the program.
  381. International Planned Parenthood Federation adds Norplant implants to its commodities list of approved contraceptives. News release.
  382. Intra-uterine contraceptive devices in nulliparous women: a retrospective study. [Dispositivo intra-uterino na contracepcao de mulheres nuligestas: um estudo retrospectivo.]
  383. Intra-uterine contraceptive devices.
  384. Intra-uterine granulation tissue with an intra-uterine contraceptive device in situ for 16 years.
  385. INTRAH trip report: Nigeria, September 27-November 2, 1985, to conduct four "Five-day family planning and oral rehydration therapy update" workshops for nurse/midwives and public health nurses in Plateau and Benue states.
  386. Intrahepatic cholestasis after oral contraception--a case of difficult differential diagnosis. [Intrahepatische Cholestase bei hormoneller Kontraception--ein Fall mit schwieriger und aufwendiger Differentialdiagnostik.]
  387. Intraperitoneal bleeding from ectopic decidua following hormonal contraception. Case report.
  388. Intrauterine bone contraceptive device: an accident of nature.
  389. Intrauterine contraception in Tianjin, People's Republic of China.
  390. Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs. [La contraccezione intrauterina dopo i 35 anni: confronto tra dispositivi potenziati al rame e al progesterone.]
  391. Intrauterine contraception.
  392. Intrauterine contraception. [Vnutrimatochnaia kontratseptsiia.]
  393. Intrauterine contraception: advances and future prospects.
  394. Intrauterine contraception: United States experience.
  395. Intrauterine contraceptive device as a risk factor of genital inflammatory process. [Vnutrimatochnyi kontratseptiv kak faktor riska vospalitelnogo protsessa genitalii]]
  396. Intrauterine contraceptive device Copper T-200 in clinical findings. [Wkladka domaciczna (IUD) Copper T-200 w obserwacji klinicznej.]
  397. Intrauterine contraceptive devices.
  398. Introducing family planning into the home economist's role: an imperative for the developing world.
  399. Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh.
  400. Introduction to evaluation of demographic impact of family planning programme.
  401. Invasive cervical cancer and combined oral contraceptives [letter]
  402. Invasive cervical cancer and combined oral contraceptives [letter]
  403. Invasive cervical cancer and combined oral contraceptives [letter]
  404. Invasive cervical cancer and combined oral contraceptives [letter]
  405. Invasive cervical cancer and combined oral contraceptives. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  406. Inventory of selected local family planning experiences in countries of the ESCAP region, Vol. 7.
  407. An investigation of contraceptive decision-making in the marital dyad.
  408. An invisible benefit: integrated project on family planning and parasite control has expanded operations multi-dimensionally.
  409. Ischemic strokes and oral contraception.
  410. Isolation and identification of actinomycetes from women using intrauterine contraceptive devices.
  411. Issues in contraceptive development.
  412. The IUD in contraceptive practice. [Lo IUD nella practica contraccettiva.]
  413. Japanese system of family planning and MCH services.
  414. Keeping teenagers in school may be the most effective contraceptive.
  415. Kenyan training program addresses increasing demand for voluntary surgical contraception.
  416. Knowledge and practice of contraception in Morocco. [Connaissance et practique de la cotraception au Maroc.]
  417. Knowledge and practice of contraception. [Connaissance et pratique de la contraception.]
  418. Knowledge and use of contraception.
  419. Knowledge content of health functionaries of Panchmahals on health, nutrition and family planning.
  420. Knowledge, attitude and practice of Malay folk methods in family planning.
  421. Knowledge, attitude, and practice of family planning among women aged 15-44 in the Yildizeli district of Sivas. [Sivas'in Yildizeli ilcesinde 15-44 yas grubu evlenmis kadinlarin aile planlamasi konusundaki bilgi, tutum ve uygulamalari.]
  422. Kwara State Family Planning Project baseline survey.
  423. Laboratory and clinical study of a new progestagen combined with ethinyl estradiol used in contraception. [Estudio de laboratorio y clinico con un nuevo progestageno combinado con etinil estradiol usado en anticoncepcion.]
  424. Lack of family planning leading to induced abortion in rural Greece.
  425. Lactation amenorrhoea: an important present-day component of family planning programmes [editorial]
  426. Lactation and postpartum infertility: the use-effectiveness of natural family planning (NFP) after term pregnancy.
  427. Lactation promoting contraception. [Diegivningsbefordrende kontraception?]
  428. Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis.
  429. Larger amounts of copper correspond to greater contraceptive effectiveness. Experiments with the ML Cu 375, the IUD with the highest copper content. [A plus de cuivre correspond une plus grande efficacite contraceptive. Experimentations a propos du ML Cu 375, le DIU le plus charge en cuivre.]
  430. Launching of Ogun State Family Planning Services, 1st - 5th July 1985.
  431. Law no. 3/84 of 24 March 1984 on sex education and family planning.
  432. Lay concepts affecting utilization of family planning services in Jamaica.
  433. Legislation on contraception and abortion for adolescents.
  434. Let's run birth control ads during Dallas and Dynasty. End this TV taboo.
  435. Levels and trends of contraceptive use in Java and Bali: data from family planning service statistics and surveys.
  436. LHRH and its analogues: potential for male contraception and for therapy of androgen-dependent syndromes.
  437. LHRH antagonists and contraception.
  438. Life-table analysis of contraceptive continuation in rural Egypt.
  439. Lipid metabolism in hormonal contraception. [Sostoianie lipidnogo obmena pri gormonalnoi kontratseptsii.]
  440. Liver and oral contraceptives. [Leber und orale kontrazeptiva.]
  441. Liver tumours associated with contraceptive hormonal treatment.
  442. Long-acting steroids for male contraception.
  443. Long-term reversible contraception with levonorgestrel-releasing Silastic rods [letter]
  444. Lucknow project for promotion of family planning among men]
  445. The macromolecular binding of prednisone in plasma of healthy volunteers including pregnant women and oral contraceptive users.
  446. Magazine versus physicians: the influence of information source on intentions to use oral contraceptives.
  447. Making twin concerns of family planning and primary health care.
  448. The makings of a new contraceptive. An effective, safe, reversible implant protects for five years.
  449. Male contraception in the preclinical evaluation.
  450. Male contraception with LHRH agonists.
  451. Male contraception--a review.
  452. Male involvement in family planning: strategies for action.
  453. Male responsibility in family planning]. Project description.
  454. Male teenagers and contraceptive use.
  455. Malignant epithelioid hemangioendothelioma of the liver in young women: relationship to oral contraceptive use.
  456. Management issues in population and family planning in the Eastern Caribbean: a case study of one project.
  457. Management of the missing intrauterine contraceptive device: report of a case.
  458. Managerial perceptions of management issues: results of a survey of family planning program managers.
  459. Managing delivery systems: identifying leverage points for improving family planning performance. Final report.
  460. Managing patients on oral contraceptives.
  461. Marketing of birth control in LDCs: with special references to India.
  462. Married women and contraceptive sterilization: factors that contribute to pre-surgical ambivalence.
  463. Marvelon; a contraceptive pill with desogestrel, a new gestagenic substance. [Marvelon; en p-pille med desogestrel, et nyt gestagen.]
  464. Maternal and child health and family planning service coverage in the Community Health Practitioner post.
  465. Maternal and child health: effective entry points for family planning.
  466. Maternal and infant death inevitable in Africa without family planning: review of the literature. [Morts maternelles et infantiles evitables en Afrique par le planning familial (revue de la litterature)]
  467. The Matlab Family Planning Health Service Project impact on family planning, fertility and child survival: a summary of key findings and their policy implications for the Bangladesh Ministry of Health and Population Control. Final report.
  468. The meaning of contraception: an authentic comparison.
  469. The measurement of arterial smooth muscle cell mitogens in the blood of oral contraceptive users.
  470. Measurement of ethynylestradiol and levonorgestrel incorporated into sustained release contraceptive formulations.
  471. Measuring contraceptive prevalence: responses from husbands and wives in Bangladesh.
  472. Measuring family planning program effort in developing countries, 1972 and 1982.
  473. Medicolegal aspects of family planning.
  474. Medicolegal issues and risk reduction in family planning practice.
  475. Men's reproductive health services in family planning settings.
  476. Mesenteric venous thrombosis and oral contraceptive use.
  477. Methodological problems in evaluation of family planning impact of programmes that are integrated with other development sectors.
  478. Methodological problems in evaluation of family planning impact of programs integrated with other sectors.
  479. Methods of birth control (condom) [Izindlela zokwelamisela khatshana (itshubhu)]
  480. Methods of birth control (IUD) [Izindlela zokwelamisela khatshana (IUD)]
  481. Metronidazole therapy on the efficacy of oral contraceptive steroid pills.
  482. Mid-term evaluation of AMREF's MCH/FP/Nutrition Project (USAID OPG Family Planning Management and Research Project Grant No. 615-0216)
  483. Migraine headaches and Wilson's Disease associated with intrauterine copper contraceptive devices.
  484. The MLCu375 intrauterine contraceptive device.
  485. Mobilizing satisfied IUD users to recruit and support new family planning acceptors: an experimental operations research field study in Sri Lanka.
  486. Mobilizing women for development: case experiences in the integration of family planning in livelihood projects.
  487. Modern contraceptive methods. [Sovremennye sredstva kontratseptsii.]
  488. Modern indications for hormonal contraception. [Attuali indicazioni della contraccezione ormonale.]
  489. More choices of birth control approaches.
  490. The nurse in family planning. [O enfermeiro no planejamento familiar.]
  491. Nutrition and family planning: an integrated program in Bali, Indonesia.
  492. The obese woman: pregnancy and contraception. [La femme obese; la grossesse et la contraception.]
  493. Objective necessity of socialist family planning: a trial discussion.
  494. Observations and recommendations on voluntarism and medical quality in Sri Lanka's surgical contraception program.
  495. OCs are currently the second most popular birth control method in U.S.
  496. Oestrogenic effects of the triphasic oral contraceptive agents [letter]
  497. Oncology patients pose challenge in choosing birth control method.
  498. One hundred clinical problems with contraception in Africa. [100 problemes cliniques de contraception en Afrique.]
  499. Operations research in health and family planning services: lessons learned in the Oyo State project.
  500. Oral contraception and cancer of the female reproductive system.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.